Shady Grove Fertility is a national leader in fertility research and is one of the only private practice fertility centers in the nation to employ a full-time dedicated research team.
Every year, Shady Grove Fertility is a major contributor to the annual scientific meeting of the American Society for Reproductive Medicine (ASRM), the national organization dedicated to the field of reproductive medicine. Over the past several years, SGF has presented the results of dozens of research studies at the ASRM annual meetings. Many of these studies are eventually published in the world’s leading scientific journals for reproductive medicine, such as Fertility and Sterility or Human Reproduction.
As a founding partner of US Fertility, SGF also contributes to the US Fertility Research Division program. Through the program, SGF researchers gain valuable insights and data from other leading fertility practices including Fertility Centers of Illinois, IVF Florida, and Reproductive Science Center of the San Francisco Bay Area.
Every year SGF publishes and presents recent findings.
You may ask, “Why does a private fertility center take the time, effort, and expense of doing research?”
We view it as part of our humanitarian responsibility to “give back” to the field.
At Shady Grove Fertility, the volume of patients we care for gives us tremendous insight into best fertility practices. We take the responsibility of ‘giving back’ to our field through research very seriously—for the benefit of all fertility patients, not just our own.
It keeps us at the forefront, performing among the best-in-class medicine.
In our constant pursuit of excellence, we continually scrutinize our practices, protocols, and methodologies—always seeking a better, safer, more efficient way of helping patients overcome infertility. This commitment to continual improvement keeps us among the forefront, innovating and refining, which ultimately provides better outcomes—not just the treatment of our patients but of those across the country who may never even meet one of our doctors, through our publications and presentations at national meetings.
We gain access to the newest medications and treatment protocols, which can greatly benefit our patients.
For patients who participate in clinical research studies, among the benefits: access to new medications before they become available to the public and/or access to treatment at potentially a lower cost.
We have the privilege of training the next generation of physician scientists in reproductive medicine.
All of the physicians at Shady Grove Fertility are grateful for the knowledge and skills they acquired at academic medical institutions as fellows in Reproductive Endocrinology and Infertility.
Shady Grove Fertility is honored to participate in academic teaching and clinical appointments through various obstetrics and gynecology residency programs. Shady Grove Fertility also participates in the highest level of training and teaching through a partnership in the combined National Institutes of Health (NIH) and Walter Reed Fellowship Program.
Our research is inspired by our spirit of collaboration.
We are an active participant in pharma-sponsored, multi-center clinical trials investigating the efficacy and safety of new medications, therapeutic devices, and treatment protocols, and are typically enrolling patients in at least one or two such clinical trials at any given time. Participation in these trials is completely voluntary and follows a transparent process of independent Institutional Review Board (IRB) review and careful informed consent. These trials allow our patients to have access to these new options and can also reduce costs of in vitro fertilization (IVF) cycles and/or medications for those patients volunteering for these sponsored trials.
We also have an extensive program of unsponsored research, including “in-house” clinical trials and reviews of our extensive records of treatments and outcomes. This research has involved issues such as optimizing embryo culture and embryo cryopreservation, embryo viability, assisted hatching, indications for and clinical value of pre-implantation genetic testing (PGT), endometrial receptivity, oxidative stress and infertility, and elective single embryo transfer (eSET).
Our research equips us to help patients feel more confident in their treatment decisions.
We’ve invested tremendous resources to help patients feel more confident in their decision making and increase their baseline knowledge. Shady Grove Fertility employs a full-time dedicated research staff, under the leadership of Director of Research and practicing board certified reproductive endocrinologist, Kate Devine, M.D. In fact, it was by SGF’s research that the advent of PRISM (Predictive Response to IVF Success Model), an exclusive success rate prediction instrument became a reality. Based on 15,000 treatment cycles from 10,000 SGF patients since 2009, PRISM leverages our own outcomes to determine probability, offering patients tremendous value and insight when making difficult treatment decisions.